Bayesian Capital Management, LP 10x Genomics, Inc. Transaction History

Bayesian Capital Management, LP

  • $838 Million
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$36.08 - $54.3 $14,432 - $21,720
-400 Reduced 2.76%
14,100 $529,000
Q4 2023

Feb 14, 2024
BUY
$34.32 - $57.55 $92,664 - $155,385
2,700 Added 22.88%
14,500 $811,000
Q3 2023

Nov 14, 2023
SELL
$40.86 - $62.98 $335,052 - $516,436
-8,200 Reduced 41.0%
11,800 $486,000
Q2 2023

Aug 14, 2023
BUY
$50.96 - $58.72 $1.02 Million - $1.17 Million
20,000 New
20,000 $1.12 Million
Q4 2022

Feb 14, 2023
BUY
$24.4 - $41.3 $327,130 - $553,709
13,407 New
13,407 $488,000

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Bayesian Capital Management, LP Portfolio

Follow Bayesian Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Bayesian Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email